Search

Your search keyword '"Cordone S."' showing total 3 results
Start Over Author "Cordone S." Topic acute coronary syndrome
3 results on '"Cordone S."'

1. Outcomes of acute coronary syndromes in coronavirus disease 2019.

Author

Cammann VL, Szawan KA, D'Ascenzo F, Gili S, Dreiding S, Würdinger M, Manka R, Stähli BE, Holy EW, Siegrist P, Jakob P, Meyer P, Iannaccone M, Di Simone E, Secco GG, Saccocci M, Bettari L, Ielasi A, Tespili M, Quadri G, Varbella F, Raposeiras-Roubin S, Abu-Assi E, Mancone M, Sardella G, Infusino F, Fedele F, Patti G, Mennuni M, Rognoni A, Bollati M, Olivotti L, Cordone S, Carugo S, Barbieri L, Gaido L, Giammaria M, Gambino A, D'Amico M, Galluzzo A, Ugo F, Trabattoni D, De Filippo O, De Ferrari GM, Vecchione C, Citro R, Ghadri JR, and Templin C

Subjects
Acute Coronary Syndrome diagnostic imaging, Acute Coronary Syndrome mortality, Aged, Aged, 80 and over, COVID-19 diagnosis, COVID-19 mortality, Coronary Angiography, Europe epidemiology, Female, Humans, Male, Middle Aged, Prognosis, Risk Factors, Time Factors, Acute Coronary Syndrome therapy, COVID-19 therapy
Published
2020
Full Text
View/download PDF

2. [ANMCO/SICI-GISE document on antiplatelet therapy in patients with acute coronary syndrome]

Author

De Luca, Leonardo, Bolognese, Leonardo, Valgimigli, Marco, Ceravolo, Roberto, Danzi, Gian Battista, Piccaluga, Emanuela, Rakar, Serena, Cremonesi, Alberto, Bovenzi, Francesco Maria, Abbate, R, Andreotti, F, Bolognese, L, Biondi Zoccai, G, Bovenzi, FM, Capodanno, D, Caporale, R, Capranzano, P, Carrabba, N, Casella, G, Cavallini, C, Ceravolo, R, Colombo, P, Conte, MR, Cordone, S, Cremonesi, A, Danzi, GB, Del Pinto, M, De Luca, G, De Luca, L, De Servi, S, Di Lorenzo, E, Di Pasquale, G, Farina, R, Fiscella, A, Formigli, D, Galli, S, Giudice, P, Gonzi, G, Greco, C, Grieco, NB, La Vecchia, L, Lazzari, M, Lettieri, C, Lettino, M, Limbruno, U, Lupi, A, Macchi, A, Marini, M, Marzilli, M, Montinaro, A, Musumeci, G, Navazio, A, Olivari, Z, Oltrona Visconti, L, Oreglia, JA, Ottani, F, Parodi, G, Pasquetto, G, Patti, G, Perkan, A, Perna, GP, Piccaluga, E, Piscione, F, Prati, F, Rakar, S, Ravasio, R, Ronco, F, Rossini, R, Rubboli, A, Saia, F, Sardella, G, Satullo, G, Savonitto, S, Sbarzaglia, P, Scorcu, G, Signore, N, Tarantini, G, Terrosu, P, Testa, L, Tubaro, M, Valente, S, Valgimigli, M, Varbella, F, Vatrano, M., ESPOSITO, GIOVANNI, De Luca, Leonardo, Bolognese, Leonardo, Valgimigli, Marco, Ceravolo, Roberto, Danzi, Gian Battista, Piccaluga, Emanuela, Rakar, Serena, Cremonesi, Alberto, Bovenzi, Francesco Maria, Abbate, R, Andreotti, F, Bolognese, L, Biondi Zoccai, G, Bovenzi, Fm, Capodanno, D, Caporale, R, Capranzano, P, Carrabba, N, Casella, G, Cavallini, C, Ceravolo, R, Colombo, P, Conte, Mr, Cordone, S, Cremonesi, A, Danzi, Gb, Del Pinto, M, De Luca, G, De Luca, L, De Servi, S, Di Lorenzo, E, Di Pasquale, G, Esposito, Giovanni, Farina, R, Fiscella, A, Formigli, D, Galli, S, Giudice, P, Gonzi, G, Greco, C, Grieco, Nb, La Vecchia, L, Lazzari, M, Lettieri, C, Lettino, M, Limbruno, U, Lupi, A, Macchi, A, Marini, M, Marzilli, M, Montinaro, A, Musumeci, G, Navazio, A, Olivari, Z, Oltrona Visconti, L, Oreglia, Ja, Ottani, F, Parodi, G, Pasquetto, G, Patti, G, Perkan, A, Perna, Gp, Piccaluga, E, Piscione, F, Prati, F, Rakar, S, Ravasio, R, Ronco, F, Rossini, R, Rubboli, A, Saia, F, Sardella, G, Satullo, G, Savonitto, S, Sbarzaglia, P, Scorcu, G, Signore, N, Tarantini, G, Terrosu, P, Testa, L, Tubaro, M, Valente, S, Valgimigli, M, Varbella, F, and Vatrano, M.

Subjects
Acute Coronary Syndrome, Platelet Aggregation Inhibitors, Human
Abstract

Antiplatelet therapy is the cornerstone of the pharmacologic management of patients with acute coronary syndrome (ACS). Over the last years, several studies have evaluated old and new oral or intravenous antiplatelet agents in ACS patients. In particular, research was focused on assessing superiority of two novel platelet ADP P2Y12 receptor antagonists (i.e., prasugrel and ticagrelor) over clopidogrel. Several large randomized controlled trials have been undertaken in this setting and a wide variety of prespecified and post-hoc analyses are available that evaluated the potential benefits of novel antiplatelet therapies in different subsets of patients with ACS. The aim of this document is to review recent data on the use of current antiplatelet agents for in-hospital treatment of ACS patients. For each drug or class of drugs, strong evidence and/or areas of uncertainty that warrant further research are highlighted by examining 10 subgroups of patients with ACS.

Published
2013

3. ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome

Author

A. Fiscella, Stefano Savonitto, Marco Marini, Rosanna Abbate, Federico Piscione, Massimiliano Conte, Ferdinando Varbella, Roberto Ceravolo, G. Gonzi, L La Vecchia, E. Di Lorenzo, N. B. Grieco, Filippo Ottani, Paolo Sbarzaglia, G. De Luca, Francesco Prati, Alessandro Lupi, Capranzano P, F. M. Bovenz, Alberto Cremonesi, G. B. Danzi, S. Cordone, A. Navazio, Serena Rakar, Francesco Bovenzi, L. Bolognese, Stefano Galli, Francesco Saia, A. Cremonesi, Giuseppe Biondi-Zoccai, L. Oltrona Visconti, Andrea Perkan, M. Del Pinto, Giampaolo Scorcu, Emanuela Piccaluga, Nazario Carrabba, E. Piccaluga, Claudio Cavallini, N. Signore, S. Rakar, G. P. Perna, Giampaolo Pasquetto, R. Ravasio, Felicita Andreotti, R. Farina, Gianni Casella, Antonio Montinaro, Giuseppe Patti, Pietro Giudice, Roberto Caporale, M. Marzilli, Serafina Valente, Corrado Lettieri, M. Vatrano, Leonardo De Luca, G. Satullo, M. Valgimigli, Maddalena Lettino, Guido Parodi, Roberta Rossini, A. Macchi, Pierfranco Terrosu, Rubboli A, Giovanni Esposito, Gian Battista Danzi, Ugo Limbruno, Giuseppe Tarantini, L. De Luca, S. De Servi, Marco Valgimigli, Zoran Olivari, Giuseppe Musumeci, Cesare Greco, D. Formigli, M. Lazzari, G. Di Pasquale, Jacopo Oreglia, Federico Ronco, Paola Colombo, Davide Capodanno, Leonardo Bolognese, Marco Tubaro, Gennaro Sardella, Luca Testa, De Luca, L., Bolognese, L., Valgimigli, M., Ceravolo, R., Danzi, G. B., Piccaluga, E., Rakar, S., Cremonesi, A., Bovenzi, F. M., Abbate, R., Andreotti, F., Biondi-Zoccai, G., Capodanno, D., Caporale, R., Capranzano, P., Carrabba, N., Casella, G., Cavallini, C., Colombo, P., Conte, M. R., Cordone, S., Del Pinto, M., De Servi, S., Di Lorenzo, E., Di Pasquale, G., Esposito, G., Farina, R., Fiscella, A., Formigli, D., Galli, S., Giudice, P., Gonzi, G., Greco, C., Grieco, N. B., La Vecchia, L., Lazzari, M., Lettieri, C., Lettino, M., Limbruno, U., Lupi, A., Macchi, A., Marini, M., Marzilli, M., Montinaro, A., Musumeci, G., Navazio, A., Olivari, Z., Oltrona Visconti, L., Oreglia, J. A., Ottani, F., Parodi, G., Pasquetto, G., Patti, G., Perkan, A., Perna, G. P., Piscione, F., Prati, F., Ravasio, R., Ronco, F., Rossini, R., Rubboli, A., Saia, F., Sardella, G., Satullo, G., Savonitto, S., Sbarzaglia, P., Scorcu, G., Signore, N., Tarantini, G., Terrosu, P., Testa, L., Tubaro, M., Valente, S., Varbella, F., and Vatrano, M.

Subjects
Drug, Acute coronary syndrome, medicine.medical_specialty, Ticagrelor, Prasugrel, media_common.quotation_subject, Antiplatelet agent, law.invention, chemistry.chemical_compound, Cangrelor, Randomized controlled trial, law, Internal medicine, medicine, media_common, Aspirin, business.industry, Antiplatelet agents, Acute coronary syndrome, Antiplatelet agents, Aspirin, Cangrelor, Clopidogrel, Prasugrel, Ticagrelor, Cardiology and Cardiovascular Medicine, medicine.disease, Clopidogrel, chemistry, Cardiology, business, Cardiology and Cardiovascular Medicine, medicine.drug
Abstract

Antiplatelet therapy is the cornerstone of the pharmacologic management of patients with acute coronary syndrome (ACS). Over the last years, several studies have evaluated old and new oral or intravenous antiplatelet agents in ACS patients. In particular, research was focused on assessing superiority of two novel platelet adenosine diphosphate (ADP) P2Y12 receptor antagonists (i.e. prasugrel and ticagrelor) over clopidogrel. Several large randomized controlled trials have been undertaken in this setting and a wide variety of pre-specified and post hoc analyses are available that evaluated the potential benefits of novel antiplatelet therapies in different subsets of patients with ACS. The aim of this document is to review recent data on the use of current antiplatelet agents for in-hospital treatment of ACS patients. For each drug or class of drugs, strong evidence and/or areas of uncertainty that warrant further research are highlighted by examining 10 subgroups of patients with ACS.

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results